Slingshot members are tracking this event:
Lilly's (LLY) Olaratumab + Doxorubicin in Soft Tissue Sarcoma Recommended for Approval by European Ad Comm
Slingshot Insights Explained
Sep 16, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords European Medicines Agency, Chmp, Olaratumab, Doxorubicin, Recommendation For Approval